Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma
Annette Gilchrist, Stephanie Lourdes Echeverria
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 23

Showing 23 citing articles:

Cancer Resistance to Immunotherapy: Comprehensive Insights with Future Perspectives
Sawsan Sudqi Said, Wisam Nabeel Ibrahim
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1143-1143
Open Access | Times Cited: 52
Chemokines and chemokine receptors in colorectal cancer; multifarious roles and clinical impact
Maria Braoudaki, Mohammed Saqif Ahmad, Denis Mustafov, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 436-449
Open Access | Times Cited: 31
Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems
Aadya Nayak, Neerada Meenakshi Warrier, Praveen Kumar
Stem Cell Reviews and Reports (2022) Vol. 18, Iss. 7, pp. 2209-2233
Open Access | Times Cited: 30
Research progress of the chemokine/chemokine receptor axes in the oncobiology of multiple myeloma (MM)
Jun Du, Lin Zheng, Xue-Hang Fu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Characterizing ligand-receptor interactions and unveiling the pro-tumorigenic role of CCL16-CCR1 axis in the microenvironment of hepatocellular carcinoma
Zongbo Dai, Yu Wang, Ning Sun, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 5
Low TYROBP expression predicts poor prognosis in multiple myeloma
Hong Luo, Chengyun Pan, Li Wang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
CCR1 inhibition sensitizes multiple myeloma cells to glucocorticoid therapy
Bert Luyckx, Maaike Van Trimpont, Fien Declerck, et al.
Pharmacological Research (2025), pp. 107709-107709
Open Access
Safety assessment of proteasome inhibitors real world adverse event analysis from the FAERS database
Jinlong Huang, Miaomiao Zhang, Jingyang Lin, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Exploring secondary extramedullary myeloma disease: a five-predictor scoring system with spotlight on double-hit cytogenetics
Tao Yi, S Jin, Zhe Wang, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Fluorophore-Labeled Pyrrolones Targeting the Intracellular Allosteric Binding Site of the Chemokine Receptor CCR1
Lara Toy, Max E. Huber, M.-W. Lee, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 7, pp. 2080-2092
Open Access | Times Cited: 3
Inflammatory Role of CCR1 in the Central Nervous System
Qi Tian, Ziang Yan, Yujia Guo, et al.
NeuroImmunoModulation (2024) Vol. 31, Iss. 1, pp. 173-182
Open Access | Times Cited: 3
The mechanism of cytokine regulation of cancer occurrence and development in the tumor microenvironment and its application in cancer treatment: a narrative review
Rongjun Qu, Yanhong Zhao, Y. Zhang
Translational Cancer Research (2024) Vol. 13, Iss. 10, pp. 5649-5663
Open Access | Times Cited: 3
A Predictive Model for Initial Platinum‐Based Chemotherapy Efficacy in Patients with Postoperative Epithelial Ovarian Cancer Using Tissue‐Derived Small Extracellular Vesicles
Shizhen Shen, Conghui Wang, Jiaxin Gu, et al.
Journal of Extracellular Vesicles (2024) Vol. 13, Iss. 8
Open Access | Times Cited: 2
Dysfunction of CCR1+ decidual macrophages is a potential risk factor in the occurrence of unexplained recurrent pregnancy loss
Yifei Sang, Yanhong Li, Ling Xu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Inhibition of CCR1 attenuates neuroinflammation via the JAK2/STAT3 signaling pathway after subarachnoid hemorrhage
Qi Tian, Yina Li, Feng Shi, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111106-111106
Closed Access | Times Cited: 5
Role of hedgehog signaling related non-coding RNAs in developmental and pathological conditions
Zanyar HajiEsmailPoor, Peyman Tabnak, Behnam Ahmadzadeh, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113507-113507
Open Access | Times Cited: 8
Chemo-рroteomic analysis of the pharmacological properties of vitamin В12 derivatives
I. Yu. Torshin, О. А. Громова, Ilia А. Dereven’kov, et al.
FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology (2024) Vol. 17, Iss. 3, pp. 345-357
Open Access | Times Cited: 1
Deciphering the impact of aging on splenic endothelial cell heterogeneity and immunosenescence through single-cell RNA sequencing analysis
Yanjing Huang, Z Y Liu, Mengke Li, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
A Graph Curvature-Based Pipeline for Discovering Immune Checkpoint Response Biomarkers
James A. Bannon, Charles R. Cantor, Bud Mishra
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
Upregulated Expression of ERBB2/HER2 in Multiple Myeloma as a Predictor of Poor Survival Outcomes
Fatih M. Uckun, Sanjive Qazi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9943-9943
Open Access | Times Cited: 2
General structure-activity/selectivity relationship patterns for the inhibitors of the chemokine receptors (CCR1/CCR2/CCR4/CCR5) with application for virtual screening of PubChem database
Maedeh Darsaraee, Sara Kaveh, Ahmad Mani‐Varnosfaderani, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-19
Open Access | Times Cited: 2
Identification and interaction mechanism of novel small molecule antagonists targeting CC chemokine receptor 1/3/5 for treatment of non-small cell lung cancer
Xiaomeng Wang, Juan Wang, Qiao Fu, et al.
Molecular Diversity (2024)
Closed Access
Histopathologic and transcriptomic phenotypes of a conditional RANKL transgenic mouse thymus
Maria M. Szwarc, Hai Lan, Vineet K. Maurya, et al.
Cytokine (2022) Vol. 160, pp. 156022-156022
Open Access | Times Cited: 1
The Expression of Serum lncRNA MIR17HG in Patients with Multiple Myeloma and Its Clinical Significance
Hongfeng Ge, Shue Li, Jiangzhou Feng, et al.
European Journal of Cancer Care (2023) Vol. 2023, pp. 1-7
Open Access
Page 1

Scroll to top